Abstract :

This study investigates the effects of structured exercise on treatment tolerance, physical function, and frailty-related outcomes in adults with colorectal cancer (CRC) receiving chemotherapy, with separate appraisal for older patients to evaluate its potential to support safe and effective treatment delivery. Using a Systematic Review methodology, this study synthesized research published between January 2021 and March 2026 from PubMed, Taylor & Francis Online, and SAGE Journals searched (1 May–1 June 2026). Data were analyzed using a narrative synthesis approach, focusing on tolerance, function, fatigue, frailty, quality of life, adherence, and safety, with bias assessed via RoB 2 and ROBINS-I. The findings indicate that of 701 studies screened, 7 reports (5 cohorts) were eligible, with no serious exercise-related adverse events. A geriatric intervention with supervised physiotherapy showed higher chemotherapy completion than usual care (45% vs 28%, p=0.037), though not isolated from concurrent nutritional therapy and medication review. Unsupervised home-based resistance training did not improve relative dose intensity, while function improved most consistently with supervised or progressive resistance programs. Unlike previous review studies, this research integrates tolerance, function, frailty, and safety outcomes into a unified narrative framework specific to the CRC chemotherapy population. The study concludes that structured exercise appears feasible and may preserve physical function, though its independent contribution to treatment tolerance remains undetermined and frailty-specific evidence is limited to one geriatric cohort. Additionally, further research is required to compare exercise delivery models using adequately powered trials and standardized frailty/tolerance measures.

---

Keywords :

Chemotherapy., Colorectal cancer, Exercise, frailty, geriatric, treatment tolerance

---

References :

1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2024 May 4;74(3):229–63. doi:10.3322/caac.21834
2. Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023 Feb;72(2):338–44. doi:10.1136/gutjnl-2022-327736
3. O’Donnell CDJ, Hubbard J, Jin Z. Updates on the Management of Colorectal Cancer in Older Adults. Cancers. 2024 May 10;16(10):1820. doi:10.3390/cancers16101820
4. Soler-González G, Sastre-Valera J, Viana-Alonso A, Aparicio-Urtasun J, García-Escobar I, Gómez-España MA, et al. Update on the management of elderly patients with colorectal cancer. Clinical and Translational Oncology. 2024;26(1):69–84. doi:10.1007/s12094-023-03243-0 PubMed PMID: 37498507.
5. Zengin B, Nazzal J, Salameh M, Akgun S, Dirican CD, Massad A, et al. Real-World Survival and Toxicity Outcomes of Fluorouracil With vs. Without Leucovorin in Metastatic Colorectal Cancer. Journal of Gastrointestinal Cancer. 2026 Jun 22;57(1):138. doi:10.1007/s12029-026-01513-y
6. Keane KF, Wickstrom J, Livinski AA, Blumhorst C, Wang TF, Saligan LN. The definitions, assessment, and dimensions of cancer-related fatigue: A scoping review. Supportive Care in Cancer. 2024;32(7):1–23. doi:10.1007/s00520-024-08615-y PubMed PMID: 38916815.
7. Salama M, Barnes D, Georghiou A, Murad M, Almalki S, Ahmed Z, et al. Anti-oxidative stress therapies prevent severe chemotherapy-induced peripheral neuropathy in colorectal cancer patients treated with oxaliplatin: a systematic review and meta-analysis. Frontiers in Oncology. 2025 Sep 10;15. doi:10.3389/fonc.2025.1642552
8. Drami I, Pring ET, Gould L, Malietzis G, Naghibi M, Athanasiou T, et al. Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing? Clinical Oncology. 2021 Dec;33(12):e540–52. doi:10.1016/j.clon.2021.05.011
9. Vergara-Fernandez O, Trejo-Avila M, Salgado-Nesme N. Sarcopenia in patients with colorectal cancer: A comprehensive review. World journal of clinical cases. 2020 Apr 6;8(7):1188–202. doi:10.12998/wjcc.v8.i7.1188 PubMed PMID: 32337193.
10. Walker RC, Pezeshki P, Barman S, Ngan S, Whyte G, Lagergren J, et al. Exercise During Chemotherapy for Cancer: A Systematic Review. Journal of Surgical Oncology. 2024 Dec 23;130(8):1725–36. doi:10.1002/jso.27845
11. Christensen JF, Simonsen C, Hojman P. Exercise Training in Cancer Control and Treatment. Comprehensive Physiology. 2019 Jan 1;9(1):165–205. doi:10.1002/j.2040-4603.2019.tb00064.x
12. Machado P, Morgado M, Raposo J, Mendes M, Silva CG, Morais N. Effectiveness of exercise training on cancer-related fatigue in colorectal cancer survivors: a systematic review and meta-analysis of randomized controlled trials. Supportive Care in Cancer. 2022 Jul 2;30(7):5601–13. doi:10.1007/s00520-022-06856-3
13. Hatlevoll I, Oldervoll LM, Wibe A, Stene GB, Stafne SN, Hofsli E. Physical exercise during adjuvant chemotherapy for colorectal cancer—a non-randomized feasibility study. Supportive Care in Cancer. 2021 Jun 8;29(6):2993–3008. doi:10.1007/s00520-020-05789-z
14. Lund CM, Vistisen KK, Olsen AP, Bardal P, Schultz M, Dolin TG, et al. The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO). British Journal of Cancer. 2021 Jun 8;124(12):1949–58. doi:10.1038/s41416-021-01367-0
15. Olsen AP, Vinther A, Ragle AM, Dolin TG, Johansen JS, Vistisen K, et al. Physical exercise program to older frail patients receiving chemotherapy for colorectal cancer – feasibility and experiences from the GERICO study. Journal of Geriatric Oncology. 2023 Jan;14(1):101382. doi:10.1016/j.jgo.2022.09.011
16. Lund CM, Dolin TG, Mikkelsen MK, Juhl CB, Vinther A, Nielsen DL. Effect of Exercise on Physical Function and Psychological Well-being in Older Patients With Colorectal Cancer Receiving Chemotherapy—A Systematic Review. Clinical Colorectal Cancer. 2020 Dec;19(4):e243–57. doi:10.1016/j.clcc.2020.05.012
17. Müller J, Weiler M, Schneeweiss A, Haag GM, Steindorf K, Wick W, et al. Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial. British Journal of Cancer. 2021 Sep 28;125(7):955–65. doi:10.1038/s41416-021-01471-1
18. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Aug 28;l4898. doi:10.1136/bmj.l4898
19. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016 Oct 12;i4919. doi:10.1136/bmj.i4919
20. Higgins, Julian P. T. Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 6. London: Cochrane; 2024.
21. Caan BJ, Brown JC, Lee C, Binder AM, Weltzien E, Ross MC, et al. Effect of home‐based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer: The FORCE randomized control trial. Cancer. 2024 May 15;130(10):1858–68. doi:10.1002/cncr.35204
22. Brown JC, Yang S, Compton SLE, Campbell KL, Cespedes Feliciano EM, Quinney S, et al. Effect of resistance training on physical function during chemotherapy in colon cancer. JNCI Cancer Spectrum. 2024;8(4). doi:10.1093/jncics/pkae058 PubMed PMID: 39012500.
23. Sánchez-González JL, Perez J, Fernández-Rodríguez EJ, Fonseca-Sánchez E, López-Mateos Y, Sanz-Blanco CM, et al. Effects of Resistance Exercise on Quality of Life, Anxiety, Depression, Sleep Quality and Inflammatory Parameters in Patients with Colorectal Cancer Undergoing Active Treatment: A Pilot Randomized Clinical Trial. Current Oncology. 2025 Nov 21;32(12):651. doi:10.3390/curroncol32120651
24. Martinez-Tapia C, Canoui-Poitrine F, Bastuji-Garin S, Soubeyran P, Mathoulin-Pelissier S, Tournigand C, et al. Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version. The Oncologist. 2016 Feb 1;21(2):188–95. doi:10.1634/theoncologist.2015-0326
25. Fontvieille A, Parent-Roberge H, Fülöp T, Pavic M, Riesco E. The Mechanisms Underlying the Beneficial Impact of Aerobic Training on Cancer-Related Fatigue: A Conceptual Review. Cancers. 2024 Feb 29;16(5):990. doi:10.3390/cancers16050990
26. Yoshida T, Delafontaine P. Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells. 2020 Aug 26;9(9):1970. doi:10.3390/cells9091970
27. Ligibel JA, Bohlke K, May AM, Clinton SK, Demark-Wahnefried W, Gilchrist SC, et al. Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline. Journal of Clinical Oncology. 2022 Aug 1;40(22):2491–507. doi:10.1200/JCO.22.00687
28. Costa SN, Ferreira LHB, Bento PCB. Effects of Home-Based Exercise Programs on Mobility, Muscle Strength, Balance, and Gait in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. Journal of Aging and Physical Activity. 2023 Aug 1;31(4):693–704. doi:10.1123/japa.2022-0221
29. Kraemer MB, Priolli DG, Reis IGM, Pelosi AC, Garbuio ALP, Messias LHD. Home-based, supervised, and mixed exercise intervention on functional capacity and quality of life of colorectal cancer patients: a meta-analysis. Scientific reports. 2022 Feb 15;12(1):2471. doi:10.1038/s41598-022-06165-z PubMed PMID: 35169171.
30. Singh B, Hayes SC, Spence RR, Steele ML, Millet GY, Gergele L. Exercise and colorectal cancer : a systematic review and meta-analysis of exercise safety , feasibility and effectiveness. 2020;1–14.
31. Pelosi AC, Rostirola GC, Pereira JS, Silva KC, Fontanari MER, Oliveira MSP, et al. Remote and Unsupervised Exercise Strategies for Improving the Physical Activity of Colorectal Cancer Patients: A Meta-Analysis. Healthcare. 2023 Mar 1;11(5):723. doi:10.3390/healthcare11050723
32. Sun Y, Witham MD, Clegg A, Taylor RS, Dibben G, McAllister D, et al. A scoping review of the measurement and analysis of frailty in randomised controlled trials. Age and Ageing. 2024 Nov 1;53(11). doi:10.1093/ageing/afae258